|
|
|
| Webinar: Peptide-Based Therapeutics: Developing and Scaling Through Innovative Technologies | Peptide-based therapeutics are thriving, prompting advances in their manufacturing. This webinar features Cambrex experts discussing liquid-phase peptide synthesis (LPPS), peptide crystallization, and impurity analysis methods. Key topics include LPPS vs. solid-phase synthesis, scalable production workflows, advantages of crystallization, and analytical techniques like HPLC and LC-MS for purity and sequencing. Click here to learn more. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | After learning about Arezou Mehrabi in part one, we now get the details to her case study of a supply chain challenged by trade sanctions, and how Big Pharma (Sanofi) collaborated with a CMO to keep delivering essential medicines. Set in Iran, circa 2018, it's a lesson for all outsourcers provided by the woman who led the charge to get manufacturing back on track. |
|
|
What's Next After FDA's DSCSA Extension? | By Carl Accettura, Global Pharma Advisory | Facing growing pressure from industry and Congress, FDA extended its enforcement deadline yet again, which has important implications for manufacturers. |
|
|
|
Making A Case For A Fixed Dose Combination Drug Strategy | Article | Pfizer CentreOne | As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care. |
|
|
|
Designing Shelf-Stable, Dry Powder Vaccines To Improve Global Access | Article | By Sana Hosseini and Kim Shepard, Lonza; and John Chen, Access to Advanced Healthcare Institute | Spray dry technology is being leveraged to create shelf-stable, dry-powder vaccines to treat and prevent the spread of tuberculosis which could significantly improve our global response to disease. |
|
|
Leveraging CDMOs In Pharma's Drive Toward Net Zero | Article | By Wouter Biesemans, Ajinomoto Bio-Pharma Services | Environmental considerations in pharmaceutical manufacturing strategies have become increasingly important in the face of additional calls to address pollution and sustainability practices globally. |
|
|
How To Select An Optimal Chromatography Silica | Article | Grace Fine Chemical Manufacturing Services | When selecting a chromatography resin, it is important to consider particle size, pore size, surface chemistry, scale, and surface area to help optimize efficiency, selectivity, and quality. |
|
|
|
|
Medicinal Chemistry - India | Pharma Expanse | Our network supports all phases of NCE development with an innovative, cost-effective model — explore our medicinal chemistry capabilities to streamline your outsourcing needs. |
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
